June 17, 2019
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549-4561
| Attn: | Donald Field |
| Re: | OncoCyte Corporation |
| Registration Statement on Form S-3 | |
| File No. 333-231980 |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, OncoCyte Corporation hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement to 4:00 p.m., Eastern Time, on Tuesday, June 18, 2019, or as soon thereafter as practicable.
Thank you for your assistance. Should you have any questions, please contact Andrew Ledbetter of DLA Piper LLP (US) at (206) 839-4845.
Very truly yours,
OncoCyte Corporation
| /s/ William Annett | |
| William Annett | |
| President and Chief Executive Officer |